Insurance giant Metlife Inc. (MET) on Wednesday caught some bullish commentary from analysts at UBS.
The firm initiated coverage on MET with a “Buy” rating and $43 price target, suggesting a massive 39% upside to the stock’s Tuesday closing price of $30.84. UBS noted the company has attractive global growth opportunities through its Alico life insurance segment.
Metlife shares fell 22 cents, or -0.7%, in Wednesday morning trading.
The Bottom Line
Shares of Metlife (MET) have a 2.40% dividend yield, based on last night’s closing stock price of $30.84. the stock has technical support in the $27-$28 price area. If the shares can firm up, we see overhead resistance around the $32-$34 price levels.
Metlife Inc. (MET) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.2 out of 5 stars.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here